BioSapien extends Pre-Series A to over $8M as Globivest joins Global Ventures, Golden Gate in backing MediChipTM
The UAE and US-based healthtech startup is developing a 3D-printed, slow-release drug delivery platform for localised cancer treatment, with new capital supporting global expansion and senior hires across R&D, regulatory, and medical affairs.